PDCD1 and neoplasm: Acquisition time was 7 days after administration of [89Zr]nivolumab, reflecting PD-1–expressing tumor-infiltrating immune cells, and 1 h after injection of [18F]BMS-986192, reflecting PD-L1 expression in tumor lesions.